Orin Green Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-12,000
| Closed | -$13.7K | – | 79 |
|
2025
Q1 | $13.7K | Buy |
+12,000
| New | +$13.7K | 0.01% | 76 |
|
2024
Q4 | – | Sell |
-12,000
| Closed | -$20.4K | – | 78 |
|
2024
Q3 | $20.4K | Hold |
12,000
| – | – | 0.01% | 83 |
|
2024
Q2 | $16.4K | Buy |
+12,000
| New | +$16.4K | 0.01% | 77 |
|
2024
Q1 | – | Sell |
-12,000
| Closed | -$118K | – | 77 |
|
2023
Q4 | $118K | Hold |
12,000
| – | – | 0.06% | 75 |
|
2023
Q3 | $100K | Hold |
12,000
| – | – | 0.06% | 69 |
|
2023
Q2 | $160K | Hold |
12,000
| – | – | 0.08% | 66 |
|
2023
Q1 | $139K | Hold |
12,000
| – | – | 0.08% | 65 |
|
2022
Q4 | $98.2K | Hold |
12,000
| – | – | 0.06% | 64 |
|
2022
Q3 | $70K | Hold |
12,000
| – | – | 0.05% | 61 |
|
2022
Q2 | $62K | Hold |
12,000
| – | – | 0.04% | 65 |
|
2022
Q1 | $109K | Buy |
+12,000
| New | +$109K | 0.07% | 65 |
|